Anzeige
Mehr »
Login
Donnerstag, 24.04.2025 Börsentäglich über 12.000 News von 692 internationalen Medien
Jetzt knallt's an der Börse! Diese Aktie hat das Zeug zum Überflieger!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DVUC | ISIN: NZAFTE0001S4 | Ticker-Symbol:
Branche
Versorger
Aktienmarkt
AUSTRALIEN
1-Jahres-Chart
AFT PHARMACEUTICALS LIMITED Chart 1 Jahr
5-Tage-Chart
AFT PHARMACEUTICALS LIMITED 5-Tage-Chart

Aktuelle News zur AFT PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
30.03.AFT PHARMACEUTICALS LIMITED: March investor update-
25.03.AFT PHARMACEUTICALS LIMITED: ASX small cap presentation 250326-
12.01.AFT PHARMACEUTICALS LIMITED: NEW YEAR LETTER TO INVESTORS1
02.12.24AFT PHARMACEUTICALS LIMITED: Disclosure of Directors and Senior Managers Relevant Intere1
02.12.24AFT PHARMACEUTICALS LIMITED: Disclosure of Directors and Senior Managers Relevant Interes-
29.11.24AFT Pharmaceuticals - Softer H1 on one-offs; recovery expected in H2308AFT Pharmaceuticals reported H125 revenues of NZ$86.7m, a 3.7% y-o-y increase, albeit lower than expected due to one-off factors such as inventory rationalisation by certain international customers...
► Artikel lesen
AFT PHARMACEUTICALS Aktie jetzt für 0€ handeln
27.11.24AFT PHARMACEUTICALS LIMITED: Disclosure of Directors and Senior Managers Relevant Int1
27.11.24AFT PHARMACEUTICALS LIMITED: Disclosure of Directors and Senior Managers Relevant Interes1
27.11.24AFT PHARMACEUTICALS LIMITED: Disclosure of Directors and Senior Managers Relevant Interes1
20.11.24AFT PHARMACEUTICALS LIMITED: AFT reports record sales and invests for growth1
19.11.24AFT PHARMACEUTICALS LIMITED: FY25 Interim Report-
19.11.24AFT PHARMACEUTICALS LIMITED: FY25 Interim Presentation-
19.11.24AFT PHARMACEUTICALS LIMITED: FY25 Interim NZX App2-
19.11.24AFT PHARMACEUTICALS LIMITED: FY25 Interim release-
12.11.24AFT PHARMACEUTICALS LIMITED: AFT appoints Allison Yorston as independent director-
07.11.24AFT PHARMACEUTICALS LIMITED: SPH Notice - Accident Compensation Corporation (ACC)1
07.11.24AFT PHARMACEUTICALS LIMITED: Change in substantial holding1
04.11.24AFT Pharmaceuticals - H125 profitability weighed down by one-offs279AFT Pharmaceuticals has released a trading update ahead of its H125 results, expecting to report a c NZ$2m operating loss for the period ending September 2024, driven by one-off factors affecting the...
► Artikel lesen
31.10.24AFT PHARMACEUTICALS LIMITED: AFT trading update-
30.09.24AFT Pharmaceuticals - Maxigesic IV reaches the Chinese shores205AFT Pharmaceuticals has taken another major step in extending its international footprint, with the signing of an exclusive license agreement for Maxigesic IV in China, the second-largest pharma market...
► Artikel lesen
Seite:  Weiter >>
24 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1